Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Chemicals | 81.8 | 81.2 | 80.9 | 128.8 | 123.9 | 121.3 | 115.8 | 64.3 |
| Biofuels | 313.7 | 346.7 | 315.1 | 304.8 | 290.2 | 249.1 | 253.8 | 199.9 |
| Total revenues | 395.4 | 427.9 | 396.0 | 385.3 | 365.8 | 322.1 | 321.4 | 264.2 |
| Revenue growth [+] | 8.1% | 32.8% | 23.2% | 45.8% | 66.6% | 67.0% | 57.2% | 51.1% |
| Chemicals | -34.0% | -33.0% | -30.2% | 100.4% | 105.5% | 79.4% | 46.3% | -25.5% |
| Biofuels | 8.1% | 39.2% | 24.1% | 52.5% | 82.1% | 98.8% | 102.5% | |
| Cost of goods sold | 347.2 | 370.2 | 367.0 | 345.3 | 337.7 | 295.0 | 297.8 | 259.2 |
| Gross profit | 48.2 | 57.8 | 29.0 | 39.9 | 28.1 | 27.1 | 23.5 | 5.0 |
| Gross margin | 12.2% | 13.5% | 7.3% | 10.4% | 7.7% | 8.4% | 7.3% | 1.9% |
| Selling, general and administrative [+] | 8.2 | 7.9 | 7.4 | 8.2 | 7.3 | 6.7 | 6.5 | 4.6 |
| General and administrative | 8.2 | 7.9 | 7.4 | 8.2 | 7.3 | 6.7 | 6.5 | 4.6 |
| Research and development | 4.1 | 3.8 | 3.4 | 3.5 | 3.3 | 3.4 | 3.5 | 3.0 |
| Other operating expenses | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| EBITDA [+] | 45.7 | 55.8 | 28.0 | 38.0 | 27.3 | 26.8 | 23.4 | 7.3 |
| EBITDA growth | 67.1% | 108.6% | 19.9% | 423.5% | 451.4% | 341.9% | -30.3% | -91.7% |
| EBITDA margin | 11.5% | 13.0% | 7.1% | 9.9% | 7.5% | 8.3% | 7.3% | 2.7% |
| Depreciation and amortization | 10.3 | 10.4 | 10.5 | 10.4 | 10.5 | 10.4 | 10.5 | 10.5 |
| EBIT [+] | 35.3 | 45.4 | 17.5 | 27.6 | 16.8 | 16.3 | 12.9 | -3.2 |
| EBIT growth | 109.9% | 177.7% | 36.0% | -955.6% | -402.7% | -448.0% | -42.3% | -104.2% |
| EBIT margin | 8.9% | 10.6% | 4.4% | 7.2% | 4.6% | 5.1% | 4.0% | -1.2% |
| Interest expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Other income (expense), net [+] | 6.9 | 2.7 | -3.7 | -3.1 | -3.8 | -0.2 | 3.2 | 4.8 |
| Unrealized gain (loss) on marketable securities | -0.6 | -3.9 | -8.5 | -7.8 | -8.0 | -3.1 | -0.1 | 2.7 |
| Other | 0.0 | 0.0 | 0.0 | 1.5 | 1.5 | | 0.0 | -1.5 |
| Pre-tax income | 42.1 | 47.9 | 13.7 | 24.4 | 12.9 | 16.0 | 15.9 | 1.5 |
| Income taxes | 0.2 | -0.8 | -1.5 | 1.8 | -3.1 | -6.6 | -10.3 | -7.9 |
| Tax rate | | -1.6% | | 7.2% | -24.1% | -41.5% | -64.8% | |
| Net income | 41.9 | 48.7 | 15.2 | 22.6 | 16.0 | 22.6 | 26.3 | 9.4 |
| Net margin | 10.6% | 11.4% | 3.8% | 5.9% | 4.4% | 7.0% | 8.2% | 3.6% |
| |
| Basic EPS [+] | $0.96 | $1.11 | $0.35 | $0.52 | $0.37 | $0.52 | $0.60 | $0.21 |
| Growth | 161.3% | 115.1% | -42.1% | 141.1% | 126.9% | 20.7% | -43.6% | -91.7% |
| Diluted EPS [+] | $0.96 | $1.11 | $0.35 | $0.52 | $0.37 | $0.52 | $0.60 | $0.21 |
| Growth | 161.3% | 115.1% | -42.1% | 141.1% | 126.9% | 20.7% | -43.6% | -91.7% |
| |
| Dividends per share [+] | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $2.74 | $2.74 | $2.74 |
| Growth | 0.0% | -91.2% | -91.2% | -91.2% | -91.2% | -15.4% | -15.4% | -15.4% |
| |
| Shares outstanding (basic) [+] | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|